Average Co-Inventor Count = 8.69
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (13 from 4,177 patents)
2. Abbvie Inc. (6 from 822 patents)
3. Enanta Pharmaceuticals, Inc. (3 from 290 patents)
4. Reata Pharmaceuticals, Inc. (1 from 61 patents)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Ireland Unlimited Company (0 patent)
19 patents:
1. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
2. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
3. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors
4. 8653141 - HIV protease inhibiting compounds
5. 8642538 - Macrocyclic hepatitis C serine protease inhibitors
6. 8426388 - Prodrugs of HIV protease inhibitors
7. 8420596 - Macrocyclic hepatitis C serine protease inhibitors
8. 8193227 - HIV protease inhibiting compounds
9. 7915411 - Anti-viral compounds
10. 7910595 - Anti-viral compounds
11. 7834043 - HIV protease inhibiting compounds
12. 7718633 - Prodrugs of HIV protease inhibitors
13. 7696226 - HIV protease inhibiting compounds
14. 6831096 - Inhibitors of neuraminidases
15. 6518305 - Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases